Andrew Darrell Krystal
Professor Emeritus of Psychiatry and Behavioral Sciences
Obstructive Sleep Apnea Screening in Pregnant Women with Chronic Hypertension awarded by (Significant Contributor). 2017 to 2019
KOR Phase 2A Study - Mod 3 (Advanced Understanding) awarded by National Institutes of Health (Principal Investigator). 2014 to 2017
Modified KOR Phase 2A Study awarded by National Institutes of Health (Principal Investigator). 2014 to 2017
FAST- MAS Phase 2A awarded by National Institutes of Health (Principal Investigator). 2013 to 2017
Janssen OBSERVEMDD0001 awarded by (Principal Investigator). 2015 to 2017
2/3 Reducing Suicide Ideation Through Insomnia Treatment (REST-IT) awarded by National Institutes of Health (Principal Investigator). 2012 to 2017
Multicenter Study of the Safety and Efficacy of JZP-110 awarded by (Principal Investigator). 2015 to 2017
Transcranial Direct Current Stimulation (tDCS) as a Treatment for Acute Fear awarded by National Institutes of Health (Principal Investigator). 2015 to 2017
The Duke Multidisciplinary Training Program in Pediatric Lung Disease awarded by National Institutes of Health (Faculty Member). 2010 to 2016
An Open-Label and Double-Blind Study to Investigate Evoked Potentials as Markers of Ketamine-Induced Cortical Plasticity awarded by (Principal Investigator). 2013 to 2015
Krystal, A. D. “Benzodiazepine receptor agonists: Indications, efficacy, and outcome.” Insomnia: Diagnosis and Treatment, 2016, pp. 375–86.
Krystal, A. D. “Psychiatric disorders and EEG.” Niedermeyer’s Electroencephalography: Basic Principles, Clinical Applications, and Related Fields: Sixth Edition, 2012, pp. 1113–27.
Krystal, A. D. “Sleep and psychiatric disorders.” Handbook of Sleep Medicine, 2011.
Richey, S. M., and A. D. Krystal. “Sleep medications: When to prescribe and rationale for use.” Sleep Disorders: Diagnosis and Therapeutics, 2008, pp. 268–80.
Krystal, Andrew D., et al. “The assessment and management of insomnia: an update..” World Psychiatry, vol. 18, no. 3, Oct. 2019, pp. 337–52. Pubmed, doi:10.1002/wps.20674. Full Text
Shi, Guangsen, et al. “A Rare Mutation of β1-Adrenergic Receptor Affects Sleep/Wake Behaviors..” Neuron, vol. 103, no. 6, Sept. 2019, pp. 1044-1055.e7. Pubmed, doi:10.1016/j.neuron.2019.07.026. Full Text
McCall, William V., et al. “Reducing Suicidal Ideation Through Insomnia Treatment (REST-IT): A Randomized Clinical Trial..” Am J Psychiatry, Sept. 2019. Pubmed, doi:10.1176/appi.ajp.2019.19030267. Full Text
Krystal, Andrew D., and Aric A. Prather. “Sleep Pharmacogenetics: The Promise of Precision Medicine..” Sleep Med Clin, vol. 14, no. 3, Sept. 2019, pp. 317–31. Pubmed, doi:10.1016/j.jsmc.2019.05.003. Full Text
McCall, William V., et al. “Prevalence of obstructive sleep apnea in suicidal patients with major depressive disorder..” J Psychiatr Res, vol. 116, Sept. 2019, pp. 147–50. Pubmed, doi:10.1016/j.jpsychires.2019.06.015. Full Text
Ashbrook, Liza H., et al. “Genetics of the human circadian clock and sleep homeostat..” Neuropsychopharmacology, Aug. 2019. Pubmed, doi:10.1038/s41386-019-0476-7. Full Text
Wilson, Sue, et al. “British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update..” J Psychopharmacol, vol. 33, no. 8, Aug. 2019, pp. 923–47. Pubmed, doi:10.1177/0269881119855343. Full Text
Scangos, Katherine W., et al. “An Electrophysiological Biomarker That May Predict Treatment Response to ECT..” J Ect, vol. 35, no. 2, June 2019, pp. 95–102. Pubmed, doi:10.1097/YCT.0000000000000557. Full Text
Asarnow, Lauren D., et al. “Circadian Preference as a Moderator of Depression Outcome Following Cognitive Behavioral Therapy for Insomnia Plus Antidepressant Medications: A Report From the TRIAD Study..” J Clin Sleep Med, vol. 15, no. 4, Apr. 2019, pp. 573–80. Pubmed, doi:10.5664/jcsm.7716. Full Text
Doghramji, Karl, et al. “PITOLISANT IN COMBINATION WITH OTHER MEDICATIONS FOR THE MANAGEMENT OF NARCOLEPSY.” Sleep, vol. 42, OXFORD UNIV PRESS INC, 2019.
Ohayon, Maurice M., et al. “Longitudinal Evolution of Narcolepsy Symptoms in Simplex and Multiplex Families.” Annals of Neurology, vol. 84, WILEY, 2018, pp. S129–30.
Beaulieu-Bonneau, S., et al. “Weekly changes in sleep and insomnia symptoms during acute treatment of persistent insomnia with behavioural or pharmacological therapy.” Journal of Sleep Research, vol. 27, WILEY, 2018.
Lunsford-Avery, J. R., et al. “SLEEPING AT HOME: FEASIBILITY AND TOLERABILITY OF AMBULATORY POLYSOMNOGRAPHY FOR USE WITH ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER.” Sleep, vol. 41, OXFORD UNIV PRESS INC, 2018, pp. A283–84.
Blanco, Marina B., et al. “To arouse or not to arouse: physiological responses from active thermogenesis versus thermoconforming in hibernating dwarf lemurs.” American Journal of Physical Anthropology, vol. 165, WILEY, 2018, pp. 30–30.
Rumble, M. E., et al. “A PRELIMINARY REPORT FROM THE "REST-IT" STUDY: SELF-REPORTED EVENINGNESS AND ACTIGRAPHIC DELAYED SLEEP TIMING CORRELATE WITH SUICIDAL IDEATION IN INDIVIDUALS WITH DEPRESSION AND INSOMNIA.” Sleep, vol. 41, OXFORD UNIV PRESS INC, 2018, pp. A237–38.
Morin, C. M., et al. “0341 SEQUENTIAL THERAPIES FOR COMORBID AND PRIMARY INSOMNIA: A RANDOMIZED CONTROLLED TRIAL.” Sleep, vol. 40, no. suppl_1, Oxford University Press (OUP), 2017, pp. A127–A127. Crossref, doi:10.1093/sleepj/zsx050.340. Full Text
Edinger, J. D., et al. “0335 DOES OBJECTIVE SLEEP DURATION MODERATE TREATMENT RESPONSE IN PATIENT WITH COMORBID DEPRESSION AND INSOMNIA? A REPORT FROM THE TRIAD STUDY.” Sleep, vol. 40, no. suppl_1, Oxford University Press (OUP), 2017, pp. A124–A124. Crossref, doi:10.1093/sleepj/zsx050.334. Full Text
Sateia, M. J., et al. “0395 CLINICAL PRACTICE GUIDELINE FOR THE PHARMACOLOGIC TREATMENT OF CHRONIC INSOMNIA IN ADULTS: AN AMERICAN ACADEMY OF SLEEP MEDICINE CLINICAL PRACTICE GUIDELINE.” Sleep, vol. 40, no. suppl_1, Oxford University Press (OUP), 2017, pp. A147–A147. Crossref, doi:10.1093/sleepj/zsx050.394. Full Text